Manulife (Manufacturers Life Insurance)’s Regenxbio RGNX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $156K | Buy |
13,048
+111
| +0.9% | +$921 | ﹤0.01% | 2638 |
|
|
2026
Q1 | $108K | Sell |
12,937
-1,225
| -9% | -$12.9K | ﹤0.01% | 2606 |
|
|
2025
Q4 | $204K | Sell |
14,162
-1,494
| -10% | -$18.6K | ﹤0.01% | 2520 |
|
|
2025
Q3 | $151K | Sell |
15,656
-1,359
| -8% | -$12K | ﹤0.01% | 2671 |
|
|
2025
Q2 | $140K | Sell |
17,015
-375
| -2% | -$3.14K | ﹤0.01% | 2686 |
|
|
2025
Q1 | $124K | Sell |
17,390
-165
| -0.9% | -$1.23K | ﹤0.01% | 2644 |
|
|
2024
Q4 | $136K | Sell |
17,555
-373
| -2% | -$3.5K | ﹤0.01% | 2756 |
|
|
2024
Q3 | $188K | Sell |
17,928
-447
| -2% | -$5.45K | ﹤0.01% | 2690 |
|
|
2024
Q2 | $215K | Buy |
18,375
+3,015
| +20% | +$46.9K | ﹤0.01% | 2579 |
|
|
2024
Q1 | $324K | Sell |
15,360
-597
| -4% | -$10.6K | ﹤0.01% | 2359 |
|
|
2023
Q4 | $286K | Sell |
15,957
-425
| -3% | -$7.49K | ﹤0.01% | 2431 |
|
|
2023
Q3 | $270K | Hold |
16,382
| – | – | ﹤0.01% | 2427 |
|
|
2023
Q2 | $327K | Buy |
16,382
+681
| +4% | +$13.1K | ﹤0.01% | 2297 |
|
|
2023
Q1 | $297K | Sell |
15,701
-12,942
| -45% | -$286K | ﹤0.01% | 2310 |
|
|
2022
Q4 | $651K | Sell |
28,643
-6,200
| -18% | -$140K | ﹤0.01% | 1830 |
|
|
2022
Q3 | $893K | Sell |
34,843
-57
| -0.2% | -$1.69K | ﹤0.01% | 1654 |
|
|
2022
Q2 | $854K | Buy |
34,900
+2,717
| +8% | +$67.9K | ﹤0.01% | 1718 |
|
|
2022
Q1 | $1.07M | Buy |
32,183
+11,740
| +57% | +$326K | ﹤0.01% | 1720 |
|
|
2021
Q4 | $666K | Sell |
20,443
-353
| -2% | -$12K | ﹤0.01% | 2077 |
|
|
2021
Q3 | $872K | Sell |
20,796
-1,696
| -8% | -$61K | ﹤0.01% | 1929 |
|
|
2021
Q2 | $874K | Buy |
22,492
+361
| +2% | +$12.9K | ﹤0.01% | 2075 |
|
|
2021
Q1 | $755K | Buy |
22,131
+1,436
| +7% | +$61.2K | ﹤0.01% | 2041 |
|
|
2020
Q4 | $939K | Buy |
20,695
+642
| +3% | +$22.4K | ﹤0.01% | 1855 |
|
|
2020
Q3 | $552K | Sell |
20,053
-348
| -2% | -$11.3K | ﹤0.01% | 1955 |
|
|
2020
Q2 | $754K | Sell |
20,401
-933
| -4% | -$34.8K | ﹤0.01% | 1750 |
|
|
2020
Q1 | $691K | Buy |
21,334
+1,159
| +6% | +$48.3K | ﹤0.01% | 1677 |
|
|
2019
Q4 | $827K | Sell |
20,175
-580
| -3% | -$22.9K | ﹤0.01% | 1773 |
|
|
2019
Q3 | $692K | Sell |
20,755
-18
| -0.1% | -$729 | ﹤0.01% | 1837 |
|
|
2019
Q2 | $1.07M | Sell |
20,773
-198
| -0.9% | -$9.88K | ﹤0.01% | 1618 |
|
|
2019
Q1 | $1.2M | Buy |
20,971
+1,367
| +7% | +$67.7K | ﹤0.01% | 1604 |
|
|
2018
Q4 | $822K | Sell |
19,604
-892
| -4% | -$52.3K | ﹤0.01% | 1675 |
|
|
2018
Q3 | $1.55M | Sell |
20,496
-703
| -3% | -$50.7K | ﹤0.01% | 1559 |
|
|
2018
Q2 | $1.52M | Buy |
21,199
+210
| +1% | +$10K | ﹤0.01% | 1615 |
|
|
2018
Q1 | $627K | Sell |
20,989
-183
| -0.9% | -$5.33K | ﹤0.01% | 2170 |
|
|
2017
Q4 | $703K | Buy |
21,172
+172
| +0.8% | +$5.18K | ﹤0.01% | 2088 |
|
|
2017
Q3 | $692K | Sell |
21,000
-817
| -4% | -$18.4K | ﹤0.01% | 2043 |
|
|
2017
Q2 | $431K | Buy |
21,817
+5,627
| +35% | +$109K | ﹤0.01% | 2406 |
|
|
2017
Q1 | $313K | Buy |
16,190
+2,223
| +16% | +$42.9K | ﹤0.01% | 2514 |
|
|
2016
Q4 | $259K | Sell |
13,967
-1,049
| -7% | -$20K | ﹤0.01% | 2586 |
|
|
2016
Q3 | $211K | Sell |
15,016
-302
| -2% | -$3.33K | ﹤0.01% | 2740 |
|
|
2016
Q2 | $122K | Buy |
15,318
+11,729
| +327% | +$130K | ﹤0.01% | 3118 |
|
|
2016
Q1 | $36K | Buy |
+3,589
| New | +$45.9K | ﹤0.01% | 3368 |
|
Other funds holding RGNX
RG
Manulife (Manufacturers Life Insurance)'s RGNX Position: Q2 2026 in Review
Manulife (Manufacturers Life Insurance) increased its Regenxbio (RGNX) stake by 0.86% in Q2 2026, buying an estimated $921 and bringing the position to 13,048 shares worth $156K. The position accounts for ﹤0.01% of the portfolio, ranked #2638.
Manulife (Manufacturers Life Insurance) first reported a position in RGNX in Q1 2016 and has held it in 42 quarters since. The position peaked at $1.55M in Q3 2018. 165 funds tracked by Wall St. Rank hold RGNX as of Q2 2026.
- Manulife (Manufacturers Life Insurance) held 13,048 shares of Regenxbio worth $156K as of Q2 2026.
- Manulife (Manufacturers Life Insurance) bought 111 Regenxbio shares in Q2 2026, an estimated $921.
- Regenxbio made up ﹤0.01% of Manulife (Manufacturers Life Insurance)'s portfolio in Q2 2026, its #2638 holding.
- Manulife (Manufacturers Life Insurance) first reported a position in Regenxbio in Q1 2016 and has held it in 42 quarters since.
- Manulife (Manufacturers Life Insurance)'s Regenxbio position peaked at $1.55M in Q3 2018.
- 165 funds tracked by Wall St. Rank held Regenxbio as of Q2 2026.
Based on Manulife (Manufacturers Life Insurance)'s 13F filing for Q2 2026, filed 14 Aug 2026.